Neostigmine Methylsulfate
Product Images NDC 75834-150

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 75834-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg_carton.jpg (1mgcarton)

This is a description for Neostigmine Methylsulfate Injection, USP. It is used for intravenous use and comes in a 10mL multiple-dose vial containing 1mg/mL Neostigmine Methylsulfate. The product is manufactured by Nivagen Pharmaceuticals, Inc. in Sacramento, CA and should be stored at controlled room temperature. Contact the free number 1877970687 for more information.*

FDA Label Image

1mg_outer Carton.jpg (1mgouter Carton)

This is Neostigmine Methylsulfate injection, with each mL containing 1 mg of Neostigmine Methylsulfate, 4.5 mg of Phenol, 0.2 mg of Sodium Acetate Trihydrate, and water for injection. It is used for intravenous use and is stored at 15° to 30°C. The product is manufactured by Nivagen Pharmaceuticals and comes in 10 x 10 mL multiple-dose vials. For more information on usage, see the package insert.*

FDA Label Image

1mg_vial.jpg (1mgvial)

Each mL of this medication contains Neostigmine methylsulfate, USP 1 mg and Phenol 4.5 mg (used as a preservative). Other ingredients include NEOStlgmlne Sodium Acetate Trihydrate 0.2 mg, Methylsulfate Water for Injection, pH adjusted, and Sodium Hydroxide/Acetic (D Injection, USP). It is used for intravenous use and is manufactured by Nivagen Pharmaceuticals Inc. This drug is stored in a carton until the time of use and should be stored at 15° to 30°C (59° to 86°F). The item is a 10mL multiple-dose vial with an NDC code of 75834-150-01.*

FDA Label Image

0.5mg_carton.jpg (Mgcarton)

This is a product description of a medication called Neostigmine Methylsulfate Injection, which comes in a 10 mL Multiple-Dose Vial with a concentration of 5 mg/10 mL (0.5 mg/mL) for intravenous use. The medication is manufactured by NIVAGEN and is available by prescription only. The packaging includes directions for use and should be stored between 10-30°C (50-86°F). Each mL contains Neostigmine Methylsulfate USP 0.5 mg, Phenol 4.5 mg, Sodium Acetate Trihydrate 0.2 mg, and water for injection, with the pH adjusted as necessary with Sodium Hydroxide and/or Hydrochloric Acid. The medication should be protected from light.*

FDA Label Image

0.5mg_outer Carton.jpg (Mgouter Carton)

Neostigmine Methylsulfate Injection, USP is a medication used for Intravenous administration purposes. It is available in the form of 10 x 10 mL Multiple-Dose Vials. Each mL contains Neostigmine Methylsulfate, USP 0.5 mg, Phenol 4.5 mg (used as a preservative), Sodium Acetate Trihydrate 0.2 mg, and Water for Injection. The drug is pH adjusted when necessary, with Sodium Hydroxide/Acetic Acid. The medication should be protected from light and stored in the carton until the time of use. The manufacturer is Nivagen Pharmaceuticals, Inc., based in Sacramento, CA 95827 USA.*

FDA Label Image

0.5mg_vial.jpg (Mgvial)

This is a medication in the form of a 10ml multiple-dose vial for intravenous use. It contains 0.5mg of Methylsulfate USP, 4.5mg of Neostigmine (used as a preservative), 0.2mg of Sodium Acetate Trihydrate, and 5 MethYISUIfate Water for Injection. Sodium Hydroxide/Acetic o Injection, USP is used to adjust the pH as necessary. The medication is manufactured by Nivagen Pharmaceuticals, Inc. It is recommended to store the medication at 15° to 30°C until use. The Batch No, Exp. Date, and Mfg. Lic. No are also provided.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.